eClinical Tech News

ImmuCell posted preliminary 2025 results and a strategic reset. Fourth-quarter sales reached $7.6 million, down 1.6% year over year,...

CorMedix Therapeutics has consolidated its leadership bench as it scales into a multi-brand anti-infectives and hospital products company. The...

Coherus Oncology has introduced the non-proprietary name tagmokitug for its anti-CCR8 monoclonal antibody and published preclinical and translational clinical...

Soleno Therapeutics has published the pivotal randomized withdrawal data for VYKAT XR (diazoxide choline extended-release) in the Journal of...

Halozyme Therapeutics and Skye Bioscience have signed a non-exclusive global collaboration and license agreement enabling Skye to use Halozyme’s...

Medicus Pharma has consolidated financial and operational leadership by appointing President Carolyn Bonner as Chief Financial Officer, following the...

INVO Fertility has realigned its leadership to accelerate a clinic-focused growth strategy. Terah Krigsvold, previously the company’s controller, has...

Nasus Pharma has moved its intranasal epinephrine program, NS002, into a Health Canada–authorized Phase 2 study, has dosed the...

Intelligent Bio Solutions has struck a strategic manufacturing partnership with Syrma Johari Medtech to scale production of its intelligent...

Arvinas has secured FDA acceptance of the NDA for vepdegestrant, its oral PROTAC estrogen receptor degrader for ESR1‑mutated ER+/HER2‑...